Press releases
Regulatory
May 19, 2022
Egetis Therapeutics raises approximately SEK 180 million through an oversubscribed rights issue
Regulatory
April 28, 2022
Egetis Therapeutics publishes prospectus relating to the Rights Issue
Regulatory
April 26, 2022
Interim report January-March 2022
Regulatory
April 20, 2022
Egetis Therapeutics’ 2021 annual report published
Regulatory
April 13, 2022
Regulatory
March 21, 2022
NOTICE OF EXTRAORDINARY GENERAL MEETING IN EGETIS THERAPEUTICS
Regulatory
March 21, 2022
Regulatory
February 17, 2022
Significant progress towards Emcitate® marketing applications in the US and Europe in 2023
Regulatory
January 18, 2022
Regulatory
December 13, 2021